Article Text

Download PDFPDF

Severe paediatric pulmonary hypertension: new management strategies
  1. A Rashid1,
  2. D Ivy2
  1. 1Consultant Paediatric Intensivist, Queens Medical Centre, Nottingham, UK
  2. 2Pediatric Heart Lung Center, The University of Colorado Health Sciences Center, and The Children’s Hospital, Denver, Colorado, USA
  1. Correspondence to:
    Dr D Ivy
    Director, Pediatric Pulmonary Hypertension Program, Section of Cardiology, Pediatric Heart Lung Center, The University of Colorado Health Sciences Center, and The Children’s Hospital, 1056 East 19th Avenue, Denver, CO 80218, USA; ivy.dunbartchden.org

Abstract

Pulmonary hypertension is a significant complication in many paediatric disease states. This article discusses current understanding of pulmonary hypertension and includes definition, diagnosis, and management. A description of the latest advances in targeted pharmacological therapy in children is also provided as well as impact on morbidity and mortality.

  • pulmonary hypertension
View Full Text

Statistics from Altmetric.com

Footnotes

  • Dr Ivy is a consultant for INO Therapeutics, Actelion, and Glaxo Smith Kline

  • Funding: Supported in part by NIH M01-RR00069 from the General Clinical Research Center branch of the National Center for Research Resources, NIH

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.